Importance of nucleic acid recognition in inflammation and autoimmunity

Annual Review of Medicine

Volumn 67, Issue , 2016, Pages 323-336

  Barrat, Franck J ^a   Elkon, Keith B ^b   Fitzgerald, Katherine A ^c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Innate immunity; Nucleic acids; Pattern recognition receptors; Therapeutics

Indexed keywords

NUCLEIC ACID; AMINOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOLOGICAL ADJUVANT; TOLL LIKE RECEPTOR; VIRUS DNA;

AGONIST; ARTICLE; AUTOIMMUNITY; CYTOSOL; ENDOSOME; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MOLECULAR RECOGNITION; MOLECULAR SENSOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; IMMUNOLOGY; METABOLISM; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; AUTOIMMUNITY; CYTOSOL; DNA, VIRAL; ENDOSOMES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEIC ACIDS; PSORIASIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VIRUS DISEASES;

EID: 84954501960     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-052814-023338     Document Type: Article

References (95)

1. Janeway CA Jr, Medzhitov R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20: 197-216
2. Hemmi H, Takeuchi O, Kawai T, et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-45
3. Akira S, Uematsu S, Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell 124: 783-801
4. Hoebe K, Jiang Z, Georgel P, et al. (2006). TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. Curr. Pharm. Des. 12: 4123-34
5. Akira S, Takeda K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511
6. Hoffmann JA. (2003). The immune response of Drosophila. Nature 426: 33-38
7. Lemaitre B, Nicolas E, Michaut L, et al. (1996). The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-83
8. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-97
9. Roach JC, Glusman G, Rowen L, et al. (2005). The evolution of vertebrate Toll-like receptors. PNAS 102: 9577-82
10. Rock FL, Hardiman G, Timans JC, et al. (1998). A family of human receptors structurally related to Drosophila Toll. PNAS 95: 588-93
11. Akira S, Hemmi H. (2003). Recognition of pathogen-Associated molecular patterns byTLRfamily. Immunol. Lett. 85: 85-95
12. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. (2007). Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13: 552-59
13. Barrat FJ, Coffman RL. (2008). Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol. Rev. 223: 271-83
14. Hayashi F, Means TK, Luster AD. (2003). Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-69
15. Schroder M, Bowie AG. (2005). TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26: 462-68
16. Zhang SY, Jouanguy E, Ugolini S, et al. (2007). TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-27
17. Hattermann K, Picard S, Borgeat M, et al. (2007). The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-Activating factor biosynthesis. FASEB J. 21: 1575-85
18. Forsbach A, Nemorin JG, Montino C, et al. (2008). Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J. Immunol. 180: 3729-38
19. Janke M, Poth J, Wimmenauer V, et al. (2009). Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8. J. Allergy Clin. Immunol. 123: 1026-33
20. Guiducci C, Gong M, Cepika AM, et al. (2013). RNA recognition by human TLR8 can lead to autoimmune inflammation. J. Exp. Med. 210: 2903-19
21. Kaisho T, Akira S. (2006). Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117: 979-87; quiz 88
22. Barreiro LB, Ben-Ali M, Quach H, et al. (2009). Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLOS Genet. 5: e1000562
23. Goubau D, Deddouche S, Reis e Sousa C. (2013). Cytosolic sensing of viruses. Immunity 38: 855-69
24. Goubau D, Schlee M, Deddouche S, et al. (2014). Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5-diphosphates. Nature 514: 372-75
25. Dempsey A, Bowie AG. (2015). Innate immune recognition ofDNA: a recent history. Virology 479-480: 146-52
26. Kim T, Pazhoor S, Bao M, et al. (2010). Aspartate-glutamate-Alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. PNAS 107: 15181-86
27. Kawai T, Akira S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-50
28. Honda K, Yanai H, Negishi H, et al. (2005). IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-77
29. Guiducci C, Ghirelli C, Marloie-Provost MA, et al. (2008). PI3K is critical for the nuclear translocation of IRF-7 and type I IFNproduction by human plasmacytoid predendritic cells in response toTLRactivation. J. Exp. Med. 205: 315-22
30. Wang J, Lau KY, Jung J, et al. (2014). Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells. Eur. J. Immunol. 44: 1130-6
31. Honda K, Ohba Y, Yanai H, et al. (2005). Spatiotemporal regulation ofMyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-40
32. Guiducci C, Ott G, Chan JH, et al. (2006). Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203: 1999-2008
33. Ku CL, von Bernuth H, Picard C, et al. (2007). Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204: 2407-22
34. Tabeta K, Georgel P, Janssen E, et al. (2004). Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. PNAS 101: 3516-21
35. Hoebe K, Du X, Georgel P, et al. (2003). Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-48
36. Her Z, Teng TS, Tan JJ, et al. (2015). Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol. Med. 7: 24-41
37. Edelmann KH, Richardson-Burns S, Alexopoulou L, et al. (2004). Does Toll-like receptor 3 play a biological role in virus infections? Virology 322: 231-38
38. Wang T, Town T, Alexopoulou L, et al. (2004). Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10: 1366-73
39. Gowen BB, Hoopes JD, Wong MH, et al. (2006). TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J. Immunol. 177: 6301-7
40. Alagarasu K, Bachal RV, Memane RS, et al. (2015). Polymorphisms in RNA sensing toll like receptor genes and its association with clinical outcomes of dengue virus infection. Immunobiology 220: 164-68
41. Diebold SS, Kaisho T, Hemmi H, et al. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-31
42. Lund JM, Alexopoulou L, Sato A, et al. (2004). Recognition of single-stranded RNA viruses by Toll-like receptor 7. PNAS 101: 5598-603
43. Lee HK, Lund JM, Ramanathan B, et al. (2007). Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315: 1398-401
44. Lund J, Sato A, Akira S, et al. (2003). Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198: 513-20
45. Fiola S, Gosselin D, Takada K, Gosselin J. (2010). TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 185: 3620-31
46. Hornung V, Latz E. (2010). Intracellular DNA recognition. Nat. Rev. Immunol. 10: 123-30
47. Kanneganti TD. (2010). Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10: 688-98
48. Dinarello CA. (2010). IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 40: 599-606
49. Burckstummer T, Baumann C, Bluml S, et al. (2009). An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10: 266-72
50. Fernandes-Alnemri T, Yu JW, Datta P, et al. (2009). AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-13
51. Hornung V, Ablasser A, Charrel-Dennis M, et al. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-Activating inflammasome with ASC. Nature 458: 514-18
52. Roberts TL, Idris A, Dunn JA, et al. (2009). HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057-60
53. Rathinam VA, Jiang Z, Waggoner SN, et al. (2010). The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11: 395-402
54. Ishikawa H, Ma Z, Barber GN. (2009). STING regulates intracellular DNA-mediated, type I interferondependent innate immunity. Nature 461: 788-92
55. Li XD, Wu J, Gao D, et al. (2013). Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341: 1390-94
56. Dai P, Wang W, Cao H, et al. (2014). Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. PLOS Pathog. 10: e1003989
57. Lam E, Stein S, Falck-Pedersen E. (2014). Adenovirus detection by the cGAS/STING/TBK1DNAsensing cascade. J. Virol. 88: 974-81
58. Lahaye X, Satoh T, Gentili M, et al. (2013). The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39: 1132-42
59. Gao D, Wu J, Wu YT, et al. (2013). Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341: 903-6
60. Krieg AM. (2002). CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-60
61. Kariko K, Buckstein M, Ni H, Weissman D. (2005). Suppression ofRNArecognition byToll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23: 165-75
62. Nestle FO, Kaplan DH, Barker J. (2009). Psoriasis. N. Engl. J. Med. 361: 496-509
63. Morizane S, Yamasaki K, Muhleisen B, et al. (2012). Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J. Investig. Dermatol. 132: 135-43
64. Ronnblom L, Eloranta ML, Alm GV. (2006). The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54: 408-20
65. van der Fits L, Mourits S, Voerman JS, et al. (2009). Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182: 5836-45
66. Yokogawa M, Takaishi M, Nakajima K, et al. (2014). Epicutaneous application of Toll-like receptor 7 agonists leads to systemic autoimmunity in wild-Type mice: a new model of systemic lupus erythematosus. Arthritis Rheumatol. 66: 694-706
67. Tsokos GC. (2011). Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-21
68. Christensen SR, Shupe J, Nickerson K, et al. (2006). Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-28
69. Garcia-Romo GS, Caielli S, Vega B, et al. (2011). Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra20
70. Barrat FJ, Meeker T, Gregorio J, et al. (2005). Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202: 1131-39
71. Elkon KB, Wiedeman A. (2012). Type I IFN system in the development and manifestations of SLE. Curr. Opin. Rheumatol. 24: 499-505
72. Means TK, Latz E, Hayashi F, et al. (2005). Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Investig. 115: 407-17
73. von Wussow P, Jakschies D, Hochkeppel H, et al. (1989). MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 32: 914-18
74. Blanco P, Palucka AK, Gill M, et al. (2001). Induction of dendritic cell differentiation by IFN-Ain systemic lupus erythematosus. Science 294: 1540-43
75. Bennett L, Palucka AK, Arce E, et al. (2003). Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-23
76. Baechler EC, Batliwalla FM, Karypis G, et al. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. PNAS 100: 2610-15
77. Kirou KA, Lee C, George S, et al. (2004). Coordinate overexpression of interferon-A-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50: 3958-67
78. Crow YJ. (2015). Type I interferonopathies: Mendelian type I interferon up-regulation. Curr. Opin. Immunol. 32: 7-12
79. Liu Y, Jesus AA, Marrero B, et al. (2014). Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371: 507-18
80. Sharma S, Campbell AM, Chan J, et al. (2015). Suppression of systemic autoimmunity by the innate immune adaptor STING. PNAS 112: E710-17
81. Wagstaff AJ, Perry CM. (2007). Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs 67: 2187-210
82. Wenzel J, Tuting T. (2008). An IFN-Associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in interface dermatitis. J. Investig. Dermatol. 128: 2392-402
83. Geary RS, Yu RZ, Levin AA. (2001). Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides. Curr. Opin. Investig. Drugs 2: 562-73
84. DubenskyTWJr, Kanne DB, Leong ML. (2013). Rationale, progress and development of vaccines utilizing STING-Activating cyclic dinucleotide adjuvants. Ther. Adv. Vaccines 1: 131-43
85. Temizoz B, Kuroda E, Ohata K, et al. (2015). TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. Eur. J. Immunol. 45: 1159-69
86. Kulkarni RR, Rasheed MA, Bhaumik SK, et al. (2014). Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. J. Virol. 88: 13990-4001
87. Ueno H, Klechevsky E, Morita R, et al. (2007). Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-42
88. Guiducci C, Coffman RL, Barrat FJ. (2009). Signalling pathways leading to IFN-Aproduction in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J. Intern. Med. 265: 43-57
89. Hooks JJ, Moutsopoulos HM, Geis SA, et al. (1979). Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301: 5-8
90. Ytterberg SR, Schnitzer TJ. (1982). Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25: 401-6
91. Bengtsson AA, Sturfelt G, Truedsson L, et al. (2000). Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9: 664-71
92. Ronnblom L, Alm GV. (2003). Systemic lupus erythematosus and the type I interferon system. Arthritis Res. Ther. 5: 68-75
93. An J, Woodward JJ, Sasaki T, et al. (2015). Cutting edge: antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction. J. Immunol. 194: 4089-93
94. Sun X, Wiedeman A, Agrawal N, et al. (2013). Increased RNase expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J. Immunol. 190: 2536-43
95. Chow J, Franz KM, Kagan JC. (2015). PRRs are watching you: localization of innate sensing and signaling regulators. Virology 479-480: 104-9